glucosamine has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ling, X; Lu, H; Qiao, L; Rui, J; Wang, A; Wang, C; Wu, J | 1 |
| Güttner, J; Jungstand, W; Schmidt, A | 1 |
2 other study(ies) available for glucosamine and Esophageal Neoplasms
| Article | Year |
|---|---|
{2-[(3-Carboxy-1-oxopropyl) amino]-2-deoxy-D-Glucose} suppresses proliferation and induces apoptosis in the human esophageal cancer cell line.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Separation; Deoxyglucose; Esophageal Neoplasms; Fas Ligand Protein; Flow Cytometry; Glucosamine; Humans; Immunohistochemistry; Proto-Oncogene Proteins c-bcl-2 | 2011 |
[Differences in the oncogenicity of N-methyl-nitrose-beta-D-glucosylamine, N-methyl-N-nitrose-beta-D-galactosylamine and their analogue sugar alcohols in rats].
Topics: Animals; Carcinogens; Esophageal Neoplasms; Galactosamine; Glucosamine; Hexosamines; Laryngeal Neoplasms; Liver Neoplasms; Neoplasms, Experimental; Nitrosamines; Pharyngeal Neoplasms; Rats; Stomach Neoplasms; Sugar Alcohols | 1971 |